Drug Pricing

Drug Pricing Recent News

First Charges Filed in Generic Drug Price Probe: Connected Stocks Sell Off
What If Trump Keeps Badmouthing Drug Pricing?
Bernie Sanders' 'Trump Proposal' To Lower Drug Prices Blocked By Senate Republicans
Trump: I'm Going To Bring Down Drug Prices
Pfizer Fined $106 Million For Anti-Epilepsy Drug
Ariad Pharmaceuticals Responds To Congressional Letter
Bernie Sanders And Rep. Cummings To Ariad: Explain Why Iclusig Now Costs $199,000 A Year
Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year
Drug Pricing Was Not Even Mentioned At The First Presidential Debate
This Pharmaceutical CEO Just Laid Out The 4 Principles Of Its 'Social Contract' With Shareholders
Clinton's Proposal To Combat Drug Price Hikes
Mylan CEO: The Healthcare System Is Broken
Mylan Cuts EpiPen Costs By Up To 50% Via Coupon
Mark Cuban Says 'It's Time To Bring Drug Pricing Under Control,' Cites Report From Harvard Business Review
Valeant's Price Cut To Hospitals Just Lip Service?
Senator Calls Out Bill Ackman, Questions His Senate Hearing Comments On Drug Pricing
Wells Fargo's Analyst Discusses Valeant's 'Apology Tour'
Hillary Clinton: 'I'm Going After' Valeant
Biotech Investors Shouldn't Fear Legislation, Even If Hillary Is President And Dems Win Senate Majority
Valeant Trends Down Following Oversight Committee Release Of Docs
Express Scripts Calls Out Valeant, Says It's 'Holding Pharmaceutical Manufacturers Accountable For Excessive Price Hikes'
Massachusetts Attorney General To Gilead Sciences: Cost Of Harvoni & Sovaldi Drugs 'May Constitute An Unfair Trade Practice In Violation Of Massachusetts Law'
Bill Ackman: Valeant Is 'Enormously' Undervalued

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved